ÂÜÀòÂÒÂ×

Shin Mukai, PhD is the Co-Founder, CEO, and CSO at New Wind Therapeutics L3C. Shin also serves as a Council Leader at U.S.-Japan Council, a Member & Mentor at Harvard Alumni Entrepreneurs, a PhD Career Advisor at Intellect Bay, and previously worked as a Scientist III at Sanofi. Shin has a strong research background in immunology and inflammation, with a focus on developing novel treatments for complex diseases. Shin holds a PhD in Bio-Organic Chemistry from The University of Western Australia and has a certificate in Entrepreneurship Essentials from Harvard Business School.